Modified Widman Flap vs Fibre Retention Osseous Resective Surgery
Launched by UNIVERSITY OF FLORENCE · Nov 2, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two surgical techniques for treating periodontal pockets (spaces between the gums and teeth) in patients with periodontitis, a serious gum disease. The two methods being compared are the Modified Widman Flap (MWF) surgery and the Fibre Retention Osseous Resective Surgery (FibReORS). The goal is to see which method is better at closing these pockets and improving gum health, particularly in areas with small bone defects at the back teeth.
To participate in this trial, you must be at least 18 years old and have periodontitis with specific conditions, such as having a gum pocket of at least 5 mm that bleeds when probed, and a bone defect that is 3 mm or less based on an X-ray. Participants can expect to receive one of the two surgical treatments and will be closely monitored for their gum health. It's important to know that this trial is currently recruiting participants and aims to provide valuable information on the best treatment options for periodontitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years;
- • Patients affected by periodontitis;
- • No systemic disease or pregnancy;
- • No systemic antibiotic therapy in 6 months preceding the enrollment;
- • Smoking ≤ 20 cigarettes/day;
- • Full-mouth plaque score (FMPS) and full- mouth bleeding score (FMBS) ≤ 15%;
- • Residual periodontal pocket ≥5 mm with bleeding on probing at posterior natural teeth;
- • Experimental pocket associated with a detectable infrabony defect ≤ 3mm at x-ray;
- • No history of periodontal surgery at the experimental site.
- Exclusion Criteria:
- • Undetectable cemento-enamel junction (CEJ) at experimental teeth;
- • Severe furcation involvement (class II and III);
- • Abutment for prosthetic rehabilitation;
- • Periodontal Pockets associated with infrabony defect \>3 mm;
- • Horizontal bone loss higher than 1/3 of the root length at experimental teeth;
- • Severe tooth mobility at baseline (class 2 or 3).
About University Of Florence
The University of Florence is a leading academic institution in Italy, renowned for its commitment to advancing scientific research and education in the medical field. With a rich history of innovation and collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes. Its multidisciplinary approach integrates cutting-edge research with clinical practice, fostering an environment that encourages the development of new therapies and treatment protocols. The University of Florence is dedicated to enhancing patient care through rigorous scientific inquiry and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Florence, Fi, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported